Lentiviral Vector CDMOs — Ranked by Signal Score
41
CDMOs tracked
34
Fully scored
11
With FDA records
28
FDA inspections
92
EMA/MHRA GMP certs
Lentiviral vectors are the workhorse of ex vivo gene therapy, used to engineer T cells for CAR-T and to modify hematopoietic stem cells. Because the vector ends up in patient-bound cells, manufacturers carry the regulatory weight of a critical starting material under full GMP.
Choosing a lentiviral vector CDMO comes down to BSL-2 containment, a mature suspension or adherent platform, robust analytics (titer, potency, RCL testing), and a clean regulatory record. The rankings below score each CDMO on FDA inspection history, GMP certification, clinical-program activity, and capacity signals.
FDA inspection outcomes across these CDMOs: 11 NAI (no action), 17 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: UNITED KINGDOM (35), United States (26), Denmark (18), Germany (8), France (7).
Last updated 2026-07-04. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
| # | CDMO | Signal Score | Quality | FDA · GMP | Capacity | Programs |
|---|---|---|---|---|---|---|
| 1 |
CR
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
|
91.7 | 98.7 | 7 insp · 11 GMP | Limited | 0 programs |
| 2 |
RP
ReciBioPharm
Keele, UK · Sodertalje, SE
|
88.0 | 100.0 | 0 insp · 3 GMP | — | 0 programs |
| 3 |
PB
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
|
85.6 | 100.0 | 3 insp · 0 GMP | — | 0 programs |
| 4 |
TF
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
|
83.1 | 97.9 | 5 insp · 10 GMP | Available | 2 programs |
| 5 |
BR
BioReliance (Merck)
Glasgow, UK · Rockville, MD
|
81.0 | 98.8 | 3 insp · 8 GMP | — | 0 programs |
| 6 |
AG
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
|
80.6 | 99.9 | 1 insp · 23 GMP | Available | 2 programs |
| 7 |
OB
OmniaBio
Hamilton, ON
|
79.5 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 8 |
PG
ProBioGen
Berlin, DE
|
78.9 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 9 |
BB
bluebird bio Manufacturing
Durham, NC
|
78.5 | — | — | — | 0 programs |
| 10 |
Lonza
Basel, Switzerland
|
78.2 | 95.1 | 2 insp · 8 GMP | — | 1 programs |
| 11 |
AA
Ascend Advanced Therapies
Philadelphia, PA
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 12 |
NG
NecstGen
Leiden, NL
|
78.1 | 100.0 | 0 insp · 1 GMP | — | 0 programs |
| 13 |
ET
Exothera
Jumet, BE
|
78.1 | 100.0 | 0 insp · 4 GMP | — | 0 programs |
| 14 |
AD
Advent Bioservices
London, UK
|
78.1 | 100.0 | 0 insp · 2 GMP | — | 0 programs |
| 15 |
BV
Biovian
Turku, Finland
|
78.0 | 99.7 | 1 insp · 4 GMP | — | 0 programs |
| 16 |
AG2
August Bioservices
San Carlos, CA
|
77.4 | 98.5 | 1 insp · 0 GMP | — | 0 programs |
| 17 |
OX
Oxford Biomedica
Oxford, United Kingdom
|
77.1 | 100.0 | 0 insp · 13 GMP | Available | 7 programs |
| 18 |
CI
Cincinnati Children's Vector Production Facility
Cincinnati, OH
|
75.2 | 100.0 | 1 insp · 0 GMP | — | 1 programs |
| 19 |
LZ
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
|
72.8 | 95.1 | 1 insp · 0 GMP | Limited | 0 programs |
| 20 |
VE
Vigene Biosciences
Rockville, MD
|
72.5 | — | — | — | 0 programs |
| 21 |
GZ
Genezen
Indianapolis, IN · Lexington, MA
|
70.7 | 84.1 | 3 insp · 0 GMP | Available | 0 programs |
| 22 |
IU
Indiana University Vector Production Facility
Indianapolis, IN
|
66.2 | — | — | — | 46 programs |
| 23 |
AN
Andelyn Biosciences
Columbus, OH
|
63.0 | — | — | Available | 0 programs |
| 24 |
RA
Recipharm Advanced Bio
Stockholm, Sweden
|
63.0 | — | — | — | 0 programs |
| 25 |
UB
uBriGene Biosciences
Shanghai, CN · Boston, MA
|
60.5 | — | — | — | 0 programs |
| 26 |
CoJourney Inc.
Ambler, PA (US operations; primary manufacturing in Hangzhou, Zhejiang, China)
|
60.0 | — | — | Limited | 0 programs |
| 27 |
TR
Takara Bio
Shiga, Japan (Kusatsu, Shiga Prefecture)
|
59.5 | — | — | — | 8 programs |
| 28 |
MA
Matica Biotechnology
College Station, TX
|
59.0 | — | — | Available | 0 programs |
| 29 |
VB
VintaBio
Cambridge, MA
|
59.0 | — | — | — | 0 programs |
| 30 |
WB
Waisman Biomanufacturing
Madison, WI
|
59.0 | — | — | — | 0 programs |
| 31 |
EB
ElevateBio BaseCamp
Waltham, MA
|
59.0 | — | — | — | 0 programs |
| 32 |
GF
GeneFab
Alameda, CA
|
59.0 | — | — | — | 0 programs |
| 33 |
VM
Vector BioMed
Cambridge, MA
|
59.0 | — | — | — | 0 programs |
| 34 |
AM
Anemocyte
Gerenzano, IT
|
59.0 | — | — | — | 0 programs |
| — |
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
|
Profiled | — | — | — | 0 programs |
| — |
VIVEbiotech
San Sebastián, Spain
|
Profiled | — | — | — | 0 programs |
| — |
Rose BioSolutions
Rockville, MD
|
Profiled | — | — | — | 0 programs |
| — |
Orphan Therapeutics Accelerator (OTXL)
Cambridge, MA
|
Profiled | — | — | — | 0 programs |
| — |
SK
SK pharmteco
Corbeil-Essonnes, FR · King of Prussia, PA
|
Profiled | — | — | — | 0 programs |
| — |
Porton Advanced
Cranbury, NJ (US HQ); GMP manufacturing sites in Suzhou, China
|
Profiled | — | — | — | 0 programs |
| — |
Vantage Vector (Demo)
Gaithersburg, MD
|
Profiled | — | — | Available | 0 programs |
What to evaluate in a Lentiviral Vector CDMO
Containment & biosafety
Lentivirus requires BSL-2 manufacturing with segregated suites and validated decontamination. Confirm the site's containment design and replication-competent lentivirus (RCL) testing strategy.
Process platform maturity
Suspension culture scales more cleanly than adherent for larger batches. Ask whether the platform is serum-free and how it performs at your target dose and patient volume.
Analytics & potency
Titer, infectivity, and potency assays drive lot release. A CDMO with qualified, established assays de-risks comparability and tech transfer.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both are shown in the rankings above and on each profile.
Lentiviral Vector CDMOs — Frequently Asked Questions
Who are the top Lentiviral Vector CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked Lentiviral Vector CDMOs include Charles River Laboratories, ReciBioPharm, Pharmaron Biologics. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many Lentiviral Vector CDMOs have FDA inspection records?
CDMO Signal tracks 11 Lentiviral Vector CDMOs with FDA inspection records and 92 EMA/MHRA GMP certificates across the group.
What should I look for in a lentiviral vector CDMO?
Prioritize BSL-2 containment, a mature suspension platform, qualified titer/potency/RCL assays, and a clean FDA and EMA/MHRA record. Match capacity to your dose and patient volume, and confirm tech-transfer support.
How is lentiviral vector manufacturing different from AAV?
Lentivirus integrates into the host genome and is produced under BSL-2 with RCL testing, typically for ex vivo cell engineering. AAV is non-integrating, made at higher volumes, and used mainly for in vivo gene therapy.
Related modalities
Other Modalities